JP Morgan Chase’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-369,763
| Closed | -$50.5M | – | 5973 |
|
|
2018
Q2 | $50.5M | Buy |
369,763
+365,992
| +9,705% | +$33.2M | 0.01% | 959 |
|
|
2018
Q1 | $297K | Sell |
3,771
-87
| -2% | -$6.42K | ﹤0.01% | 4223 |
|
|
2017
Q4 | $263K | Buy |
+3,858
| New | +$200K | ﹤0.01% | 4311 |
|
|
2017
Q2 | – | Sell |
-2,686
| Closed | -$87K | – | 5414 |
|
|
2017
Q1 | $87K | Buy |
+2,686
| New | +$67K | ﹤0.01% | 4373 |
|
|
2016
Q3 | – | Sell |
-412
| Closed | -$8K | – | 4987 |
|
|
2016
Q2 | $8K | Buy |
412
+193
| +88% | +$3.49K | ﹤0.01% | 4388 |
|
|
2016
Q1 | $4K | Buy |
+219
| New | +$3.53K | ﹤0.01% | 4429 |
|
|
2015
Q4 | – | Sell |
-50,301
| Closed | -$928K | – | 4883 |
|
|
2015
Q3 | $928K | Sell |
50,301
-180,996
| -78% | -$4.52M | ﹤0.01% | 3153 |
|
|
2015
Q2 | $7.83M | Sell |
231,297
-114,015
| -33% | -$4.59M | ﹤0.01% | 2103 |
|
|
2015
Q1 | $16.6M | Sell |
345,312
-17,207
| -5% | -$781K | ﹤0.01% | 1563 |
|
|
2014
Q4 | $8.06M | Buy |
362,519
+285,139
| +368% | +$6.58M | ﹤0.01% | 2090 |
|
|
2014
Q3 | $1.47M | Buy |
77,380
+32,493
| +72% | +$775K | ﹤0.01% | 3122 |
|
|
2014
Q2 | $1.21M | Sell |
44,887
-42,388
| -49% | -$1.07M | ﹤0.01% | 2777 |
|
|
2014
Q1 | $2.83M | Sell |
87,275
-144,958
| -62% | -$4.71M | ﹤0.01% | 2381 |
|
|
2013
Q4 | $5.53M | Buy |
+232,233
| New | +$6.49M | ﹤0.01% | 2108 |
|
JP Morgan Chase's FMI Position: Q3 2018 in Review
JP Morgan Chase sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 369,763 shares — an estimated $50.5M sold.
JP Morgan Chase first reported a position in FMI in Q4 2013 and held it in 14 quarters. The position peaked at $50.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- JP Morgan Chase reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- JP Morgan Chase sold 369,763 Foundation Medicine, Inc. shares in Q3 2018, an estimated $50.5M.
- JP Morgan Chase first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 14 quarters.
- JP Morgan Chase's Foundation Medicine, Inc. position peaked at $50.5M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.